X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA CADILA HEALTHCARE ELDER PHARMA/
CADILA HEALTHCARE
 
P/E (TTM) x -0.2 32.4 - View Chart
P/BV x 0.1 6.4 1.6% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ELDER PHARMA   CADILA HEALTHCARE
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
CADILA HEALTHCARE
Mar-17
ELDER PHARMA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs380460 82.6%   
Low Rs188305 61.6%   
Sales per share (Unadj.) Rs491.292.1 533.3%  
Earnings per share (Unadj.) Rs-3.214.8 -21.5%  
Cash flow per share (Unadj.) Rs14.418.5 78.0%  
Dividends per share (Unadj.) Rs03.20 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.568.0 553.8%  
Shares outstanding (eoy) m20.541,023.74 2.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.64.2 13.9%   
Avg P/E ratio x-89.325.8 -345.8%  
P/CF ratio (eoy) x19.720.7 95.2%  
Price / Book Value ratio x0.85.6 13.4%  
Dividend payout %021.6 0.0%   
Avg Mkt Cap Rs m5,833391,581 1.5%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m2,17915,002 14.5%   
Avg. sales/employee Rs ThNM5,594.5-  
Avg. wages/employee Rs ThNM890.1-  
Avg. net profit/employee Rs ThNM899.9-  
INCOME DATA
Net Sales Rs m10,08994,295 10.7%  
Other income Rs m2571,286 20.0%   
Total revenues Rs m10,34695,581 10.8%   
Gross profit Rs m-79219,036 -4.2%  
Depreciation Rs m3613,750 9.6%   
Interest Rs m2,756450 612.5%   
Profit before tax Rs m-3,65316,122 -22.7%   
Minority Interest Rs m0338 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,713-3 -123,756.7%   
Tax Rs m1251,289 9.7%   
Profit after tax Rs m-6515,168 -0.4%  
Gross profit margin %-7.820.2 -38.9%  
Effective tax rate %-3.48.0 -42.9%   
Net profit margin %-0.616.1 -4.0%  
BALANCE SHEET DATA
Current assets Rs m9,24060,223 15.3%   
Current liabilities Rs m9,99853,058 18.8%   
Net working cap to sales %-7.57.6 -98.8%  
Current ratio x0.91.1 81.4%  
Inventory Days Days4670 66.3%  
Debtors Days Days6088 68.0%  
Net fixed assets Rs m10,12472,984 13.9%   
Share capital Rs m2061,024 20.1%   
"Free" reserves Rs m5,58268,576 8.1%   
Net worth Rs m7,73469,600 11.1%   
Long term debt Rs m4,88924,684 19.8%   
Total assets Rs m22,882152,207 15.0%  
Interest coverage x-0.336.8 -0.9%   
Debt to equity ratio x0.60.4 178.3%  
Sales to assets ratio x0.40.6 71.2%   
Return on assets %11.810.3 114.6%  
Return on equity %-0.821.8 -3.9%  
Return on capital %22.317.9 124.4%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30721,280 1.4%   
Fx outflow Rs m12510,874 1.2%   
Net fx Rs m18110,406 1.7%   
CASH FLOW
From Operations Rs m11,75413,495 87.1%  
From Investments Rs m-561-29,103 1.9%  
From Financial Activity Rs m-6,76223,158 -29.2%  
Net Cashflow Rs m4,4327,556 58.7%  

Share Holding

Indian Promoters % 39.6 74.8 52.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 8.3 90.4%  
FIIs % 16.8 5.9 284.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 11.0 328.2%  
Shareholders   16,479 44,069 37.4%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DIVIS LABORATORIES  FDC LTD.  SUN PHARMA  PLETHICO PHARMA  TTK HEALTHCARE  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Sensex Touching Record Highs, Rally in Banking Stocks and Key Stocks in Action Today(Pre-Open)

BSE Sensex is on a roll. The index touched a record high of 35,000 on Wednesday and further inched upwards to end yesterday's trade at a level of 35,260.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS